On 25 September 2017
Vista Pharmaceuticals announced that an Abbreviated New Drug Application has been submitted by the Company to USFDA on 25 September 2017 for a cardiac drug. The project is partnered with an US based company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content